Obesity has become a global epidemic and is a major risk factor for type 2 diabetes, cardiovascular diseases and certain cancers. Evidence has accumulated that the gut microbiota is an important environmental factor contributing to obesity by altering host energy harvest and storage1,2. Gut microbiota transplantation experiments suggest a causal relationship between the gut microbiota and obesity development3, and human studies have associated gut microbial dysbiosis with obesity4,5 and metabolic disorders such as type 2 diabetes6,7. In general, obese individuals show decreased bacterial diversity5 and gene richness8,9. It was originally reported that obesity was associated with a lower ratio of Bacteroidetes to Firmicutes4, and it has been reported that this ratio increases after weight loss induced by dietary intervention4 or Roux-en-Y gastric bypass10,11. Nevertheless, this view has been challenged by subsequent studies that have provided conflicting findings12,13.
肥胖已成为全球流行病,是2型糖尿病、心血管疾病和某些癌症的主要危险因素。已有证据表明,肠道微生物群是一个重要的环境因素,通过改变宿主的能量收获和储存而导致肥胖1,2。肠道微生物群移植实验表明肠道微生物群与肥胖症发展之间存在因果关系3,人类研究表明肠道微生物失调与肥胖症4,5和代谢紊乱如2型糖尿病6,7相关。一般来说,肥胖者的细菌多样性和基因丰富度降低8,9。最初有报道称,肥胖与类杆菌与厚壁菌的比率较低有关,有报道称,通过饮食干预或Roux-en-Y胃旁路术诱导体重减轻后,这一比率增加10,11。然而,这一观点受到了后续研究的挑战,这些研究提供了相互矛盾的发现12,13。<br>
正在翻译中..